Paper36969230
Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension.
Guo Y and 4 others. Front Immunol, 2023. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension. Papers, record 36969230. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969230
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis | Major topic |
| Hypertension, Portal | Major topic |
| Humans |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21391523 | Systemic vasculitis. | Am Fam Physician | 2011 | https://conductscience.org/library/papers/21391523 | PubMed |
| 2 | 35083817 | Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis. | Cell Prolif | 2022 | https://conductscience.org/library/papers/35083817 | PubMed |
| 3 | 25492994 | Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25492994 | PubMed |
| 4 | 33060124 | Targeting the gut-liver-immune axis to treat cirrhosis. | Gut | 2021 | https://conductscience.org/library/papers/33060124 | PubMed |
| 5 | 36642653 | Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host. | J Allergy Clin Immunol | 2023 | https://conductscience.org/library/papers/36642653 | PubMed |
| 6 | 36368305 | Macrophages in health and disease. | Cell | 2022 | https://conductscience.org/library/papers/36368305 | PubMed |
| 7 | 27056726 | Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats. | Am J Physiol Gastrointest Liver Physiol | 2016 | https://conductscience.org/library/papers/27056726 | PubMed |
| 8 | 36577100 | Alcohol-Associated Hepatitis. | N Engl J Med | 2022 | https://conductscience.org/library/papers/36577100 | PubMed |
| 9 | 34703031 | Cirrhosis-associated immune dysfunction. | Nat Rev Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/34703031 | PubMed |
| 10 | 35750137 | Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. | J Hepatol | 2022 | https://conductscience.org/library/papers/35750137 | PubMed |
| 11 | 36193976 | Intestinal homeostasis in autoimmune liver diseases. | Chin Med J (Engl) | 2022 | https://conductscience.org/library/papers/36193976 | PubMed |
| 12 | 36626620 | The evolving role of liver sinusoidal endothelial cells in liver health and disease. | Hepatology | 2023 | https://conductscience.org/library/papers/36626620 | PubMed |
| 13 | 36304507 | Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice. | J Clin Transl Hepatol | 2022 | https://conductscience.org/library/papers/36304507 | PubMed |
| 14 | 28461703 | Does niche competition determine the origin of tissue-resident macrophages? | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/28461703 | PubMed |
| 15 | 31205028 | More friend than foe: the emerging role of neutrophils in tissue repair. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31205028 | PubMed |
| 16 | 30897205 | Origins of CD4+ circulating and tissue-resident memory T-cells. | Immunology | 2019 | https://conductscience.org/library/papers/30897205 | PubMed |
| 17 | 25962122 | Common clonal origin of central and resident memory T cells following skin immunization. | Nat Med | 2015 | https://conductscience.org/library/papers/25962122 | PubMed |
| 18 | 35021063 | Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. | Cell | 2022 | https://conductscience.org/library/papers/35021063 | PubMed |
| 19 | 31840358 | Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. | Hepatol Res | 2020 | https://conductscience.org/library/papers/31840358 | PubMed |
| 20 | 34440714 | Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. | Cells | 2021 | https://conductscience.org/library/papers/34440714 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42781345 | Correlation analysis of serum cytokine levels and immune inflammatory factors in cirrhotic portal hypertension. | J Med Biochem | 2026 | https://conductscience.org/library/papers/42781345 |
Source PubMed
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969230
GET https://conductscience.org/api/papers/v1/36969230/references?page=2